Reporter Jan 6 2023
Anti-nausea drug response in children
Jan. 10, 2023—Genetic variation in a metabolic enzyme was not associated with response to the anti-nausea drug odansetron in children, Vanderbilt researchers report.
Novel lung cancer biomarker
Jan. 9, 2023—Autoantibodies against the p53 tumor suppressor protein may be a novel biomarker for identifying people, especially African Americans, at high risk for lung cancer.
Early effects of Huntington disease
Jan. 6, 2023—Impairments in brain executive function happen earlier than motor symptoms in people with the gene mutation that causes Huntington disease, suggesting younger ages and cognitive symptoms be considered for any future clinical trials.
MicroRNAs linked to lipid damage
Jan. 6, 2023—VUMC researchers have linked microRNAs with systemic lipid peroxidation, a discovery that could point to new therapeutic targets for a variety of diseases.
VUMC researchers upend dogma about vasopressin production
Jan. 5, 2023—Vanderbilt investigators have discovered that vasopressin, which has long been thought to be produced only in the brain, is also produced in the kidney.
Infectious disease expert Edwards ends storied career
Jan. 5, 2023—Vanderbilt's Kathryn Edwards, MD, internationally recognized for her countless contributions to vaccine evaluation and implementation, public health advocacy, and the mentorship and training of new generations of experts in infectious disease over the past four decades, retired on Dec. 31, 2022.
VUMC-led COVID-19 clinical trial platform goes international
Jan. 5, 2023—The ACTIV-4 Host Tissue clinical trial platform, which is designed to investigate therapies targeting the host tissue response to COVID-19 to mitigate lung injury, is now being expanded internationally.
Three elected to the American Pediatric Society
Jan. 5, 2023—Three physicians in the Vanderbilt Department of Pediatrics have been elected to the American Pediatric Society.
New approach outperforms existing cancer susceptibility models
Jan. 5, 2023—A new approach for conducting gene-based analyses for cancer susceptibility created at Vanderbilt outperforms existing models.
VUMC strongly recommends COVID-19 bivalent booster vaccination as new COVID-19 variants appear in our region
Jan. 4, 2023—With the development of new variants of the COVID-19 virus across the U.S. and the world, Vanderbilt University Medical Center recommends getting the bivalent booster vaccination.
Study shows peer messaging tool can be successfully implemented in the nursing workforce
Jan. 3, 2023—A new study shows that a tool developed at Vanderbilt University Medical Center to address disrespectful workplace behaviors through trained peer-to-peer messaging can be successfully implemented in the nursing workforce with the appropriate support.
Terhune named Senior Vice President for Educational Affairs
Jan. 3, 2023—Vanderbilt's Kyla Terhune, MD, MBA, Vice President for Educational Affairs and Associate Dean for Graduate Medical Education, has been named Senior Vice President for Educational Affairs.